FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024

FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31. FGEN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day and thank you for standing by. Welcome to the FibroGen’s First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’...